These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 18389079)
1. The interferon response inhibits HIV particle production by induction of TRIM22. Barr SD; Smiley JR; Bushman FD PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079 [TBL] [Abstract][Full Text] [Related]
2. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T; J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524 [TBL] [Abstract][Full Text] [Related]
3. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter. Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615 [TBL] [Abstract][Full Text] [Related]
5. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements. Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949 [TBL] [Abstract][Full Text] [Related]
6. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Gao B; Duan Z; Xu W; Xiong S Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648 [TBL] [Abstract][Full Text] [Related]
7. TRIM22. A Multitasking Antiviral Factor. Pagani I; Poli G; Vicenzi E Cells; 2021 Jul; 10(8):. PubMed ID: 34440633 [TBL] [Abstract][Full Text] [Related]
9. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. Di Pietro A; Kajaste-Rudnitski A; Oteiza A; Nicora L; Towers GJ; Mechti N; Vicenzi E J Virol; 2013 Apr; 87(8):4523-33. PubMed ID: 23408607 [TBL] [Abstract][Full Text] [Related]
10. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection. Vicenzi E; Poli G Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252 [TBL] [Abstract][Full Text] [Related]
11. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A. Yang C; Zhao X; Sun D; Yang L; Chong C; Pan Y; Chi X; Gao Y; Wang M; Shi X; Sun H; Lv J; Gao Y; Zhong J; Niu J; Sun B Cell Mol Immunol; 2016 Jan; 13(1):94-102. PubMed ID: 25683609 [TBL] [Abstract][Full Text] [Related]
12. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8. Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298 [TBL] [Abstract][Full Text] [Related]
13. Control of FoxO4 Activity and Cell Survival by TRIM22 Directs TLR3-Stimulated Cells Toward IFN Type I Gene Induction or Apoptosis. Oteiza A; Mechti N J Interferon Cytokine Res; 2015 Nov; 35(11):859-74. PubMed ID: 26237181 [TBL] [Abstract][Full Text] [Related]
14. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease. Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607 [TBL] [Abstract][Full Text] [Related]
15. Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines. Turrini F; Saliu F; Forlani G; Das AT; Van Lint C; Accolla RS; Berkhout B; Poli G; Vicenzi E Virus Res; 2019 Aug; 269():197631. PubMed ID: 31136823 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation. Obad S; Olofsson T; Mechti N; Gullberg U; Drott K J Interferon Cytokine Res; 2007 Oct; 27(10):857-64. PubMed ID: 17970695 [TBL] [Abstract][Full Text] [Related]
17. A 5' extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1. Gao B; Wang Y; Xu W; Duan Z; Xiong S J Immunol; 2010 Aug; 185(4):2314-23. PubMed ID: 20631312 [TBL] [Abstract][Full Text] [Related]
18. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Bouazzaoui A; Kreutz M; Eisert V; Dinauer N; Heinzelmann A; Hallenberger S; Strayle J; Walker R; Rübsamen-Waigmann H; Andreesen R; von Briesen H Virology; 2006 Dec 5-20; 356(1-2):79-94. PubMed ID: 16926043 [TBL] [Abstract][Full Text] [Related]
19. miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling. Tian H; He Z Yonsei Med J; 2018 Jun; 59(4):511-518. PubMed ID: 29749134 [TBL] [Abstract][Full Text] [Related]
20. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. Sawyer SL; Emerman M; Malik HS PLoS Pathog; 2007 Dec; 3(12):e197. PubMed ID: 18159944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]